REGENXBIO, Inc. (RGNX)

8.35 -0.18 (-2.11%) USD  |  NASDAQ  |  Feb 26, 10:26
More

REGENXBIO Stock Based Compensation (Annual)

Stock Based Compensation (Annual) Chart

View Stock Based Compensation (Annual) for RGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual) Range, Past 5 Years

View Stock Based Compensation (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual) Benchmarks

View Stock Based Compensation (Annual) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
Omeros Corp. Upgrade
AbbVie, Inc. Upgrade
CytomX Therapeutics, Inc. Upgrade
Krystal Biotech, Inc. Upgrade